MAVIPAN: My Life and the COVID-19 Pandemic

The MAVIPAN Protocol: For a Structured Response to the Psychosocial Consequences of the Restrictive Measures Imposed by the Global Health COVID-19 Pandemic

The health crisis imposed by COVID-19 is forcing major worldwide social reorganization that will have profound consequences on our society. Currently, one-third of the world's population (~3 billion individuals) is living under some kind of isolation or quarantine measures, causing an unprecedented and rapidly evolving psychosocial crisis.

The psychosocial consequences of this health crisis will persist long after restriction measures are lifted and the pandemic is over. This impact will be significant for individuals facing unique contexts or challenges (e.g., older adults, individuals living with a disability, underprivileged families) and will most likely exacerbate existing social and gender inequalities in health and human development.

There is an urgent need for information on the evolution of the psychosocial dimensions of health and coping strategies used by our population and our health and social services structures. Thus, this study is designed to accelerate the availability of high-quality, real-time evidence within health and social services structures to address, support and minimize psychosocial consequences of the COVID-19 pandemic. Through constantly evolving research questions responsive to the course of the pandemic evolution, the rapid system transformations and adaptation of services, and knowledge users (KUs) needs, MAVIPAN aims to address, document, monitor, and evaluate the following:

1. Individuals and families' adjustments and mitigation strategies, especially for those considered vulnerable and in high-risk contexts.
2. Healthcare and social services workers and managers' adjustments and mitigation strategies.
3. The organization of service structures.
4. The social and economic response.

To achieve these objectives, we use a mixed methods study design that combines quantitative questionnaires and qualitative interviews to deepen our understanding of elements such as the coping strategies used during the pandemic. A first measure was taken during lock-down as well as a follow-up at 3 months. Another follow-up will be made at 7 months. At least one per year follow-up will be made over the course of the study (5 years). Additional measures may be taken depending on the evolution of the pandemic and the sanitary measures put in place by the authorities.

Study Overview

• Status: Recruiting
• Conditions: Psychosocial Impacts of the COVID-19 Pandemic
• Intervention / Treatment: Other: No intervention, this is an observational study that uses validated questionnaires and qualitative interviews..

• Study Type: Observational
• Enrollment (Anticipated): 5000

Contacts and Locations

• Study Contact: Name: Annie LeBlanc, PhD; Phone Number: 418-663-5712; Email: annie.leblanc@fmed.ulaval.ca
• Study Contact Backup: Name: Marie Baron, PhD; Email: marie.baron.ciussscn@ssss.gouv.qc.ca

Study Locations

• Canada
  • Québec, Canada, G1J 0A4
    • Recruiting
    • VITAM-Research Center in Sustainable Health
    • Contact: Annie LeBlanc, PhD; Phone Number: 418-663-5712; Email: annie.leblanc@fmed.ulaval.ca

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

MAVIPAN is open to any individuals aged 14 and over across the Province of Quebec. We are particularly invested in recruiting vulnerable populations (e.g., older adults, individuals living with a disability or a chronic or mental health condition, child protection families, individuals living in institutional settings) and populations that have become vulnerable because of the COVID-19 context (e.g., healthcare and social services workers, adolescents, caregivers).

Description

Inclusion Criteria:

• General population

Exclusion Criteria:

• Not a resident of the province of Quebec
• Age under 14

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression, Anxiety and Stress Scale-21 (DASS-21)	The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.	Baseline (measured during lockdown in March 2020)
Depression, Anxiety and Stress Scale-21 (DASS-21)	The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.	3 months
Depression, Anxiety and Stress Scale-21 (DASS-21)	The DASS-21 is a measure of depression, anxiety and stress symptoms. The score on each subscale varies from 0 to 21. A higher score means a higher level of symptoms.	7 months
Insomnia Severity Index	Scores vary between 0 and 28. A higher score means greater insomnia severity.	Baseline (measured during lockdown in March 2020)
Insomnia Severity Index	Scores vary between 0 and 28. A higher score means greater insomnia severity.	3 months
Insomnia Severity Index	Scores vary between 0 and 28. A higher score means greater insomnia severity.	7 months
Warwick-Edinburgh Mental Well-Being Scale	Scores range from 7 to 35 and higher scores indicate higher positive well-being.	Baseline (measured during lockdown in March 2020)
Warwick-Edinburgh Mental Well-Being Scale	Scores range from 7 to 35 and higher scores indicate higher positive well-being.	3 months
Warwick-Edinburgh Mental Well-Being Scale	Scores range from 7 to 35 and higher scores indicate higher positive well-being.	7 months
Hostility subscale- Symptoms Checklist-90-Revised	Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility	Baseline (measured during lockdown in March 2020)
Hostility subscale- Symptoms Checklist-90-Revised	Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility	3 months
Hostility subscale- Symptoms Checklist-90-Revised	Only the Hostility subscale that measures thoughts, feelings and actions characteristic of anger is used. Scores range from 6 to 24 and higher scores indicate higher level of hostility	7 months
Substance use	These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.	Baseline (measured during lockdown in March 2020)
Substance use	These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.	3 months
Substance use	These are self-report questions that measure the change in consumption level of different substances such as alcool, prescriptions medications and illicit drugs prior and after the lockdown.	7 months
Brief COPE	We use a subset of questions taken from the Brief Cope which measures coping strategies.	Baseline (measured during lockdown in March 2020)
Dyadic Adjustment Scale	We use a subset of questions taken from the Dyadic Adjustment Scale which measures couple satisfaction.	Baseline (measured during lockdown in March 2020)
Parental Stress Index	We only use the Interaction subscale which measures the extent to which the parent believes the child is not meeting expectations and finds interactions with the child are not reinforcing his parenting role.	Baseline (measured during lockdown in March 2020)
Child Conflict Tactic Scale	We use a subset of questions that measures the presence of minor physical abuse as well as psychological abuse.	Baseline (measured during lockdown in March 2020)
Strengths and Difficulties Questionnaire	We use a subset of questions that aim to measure different child behaviors and personality caracteristics.	Baseline (measured during lockdown in March 2020)
Healthcare workers adaptation	We use a series of questions that assess different changes that may have occured in their work, as well as a series of beliefs they may hold concerning their work and their patients/clients.	Baseline (measured during lockdown in March 2020)

Collaborators and Investigators

• Sponsor: Laval University
• Collaborators: CISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre de recherche CERVO; Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale; Centre de recherche universitaire sur les jeunes et les familles; Réseau québécois de recherche sur le vieillissement; Participation sociale et villes inclusives; Société inclusive; Centre intégré de santé et de services sociaux de la Côte-Nord; Fondation Mirella et Lino Saputo; Ville de Québec; Living Lab de Charlevoix; Centre intégré de santé et de services sociaux du Bas St-Laurent; Réseau provincial de recherche en adaptation réadaptation; Réseau international sur le Processus de production du handicap; Centre de recherche intégrée pour un système apprenant en santé et services sociaux; Regroupement des organismes de personnes handicapées de la région 03
• Investigators: Principal Investigator: Annie LeBlanc, PhD, Faculty of Medecine, Laval University

Publications and helpful links

General Publications

• LeBlanc A, Baron M, Blouin P, Tarabulsy G, Routhier F, Mercier C, Despres JP, Hébert M, De Koninck Y, Cellard C, Collin-Vézina D, Côté N, Dionne É, Fleet R, Gagné MH, Isabelle M, Lessard L, Menear M, Merette C, Ouellet MC, Roy MA, Saint-Jacques MC, Savard C; MAVIPAN Research Collaboration. For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: the MAVIPAN longitudinal prospective cohort study protocol. BMJ Open. 2022 Apr 4;12(4):e048749. doi: 10.1136/bmjopen-2021-048749.

Helpful Links

• Official web site of the study

Study record dates

Study Major Dates

• Study Start (Actual): April 29, 2020
• Primary Completion (Anticipated): April 29, 2025
• Study Completion (Anticipated): April 29, 2025

Study Registration Dates

• First Submitted: September 24, 2020
• First Submitted That Met QC Criteria: October 2, 2020
• First Posted (Actual): October 5, 2020

Study Record Updates

• Last Update Posted (Actual): October 5, 2020
• Last Update Submitted That Met QC Criteria: October 2, 2020
• Last Verified: October 1, 2020

More Information

Terms related to this study

• Keywords: Covid19; Psychological Distress; Coping Behaviors
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: To be assigned (EGMS)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No